Blog

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Photo from CPE/LinkedIn

Jul 11, 2024, 15:38

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Cancer Patients Europe (CPE) shared on LinkedIn:

“CPE, in collaboration with the Alliance for Regenerative Medicine and Fondazione Telethon, has launched a Call to Action on the implementation of the EU Joint Clinical Assessment (JCAs) for Advanced Therapy Medicinal Products (ATMPs).

With the support of more than 30 signatories, we are urging the HTA Coordination Group and JCA assessors to ensure that JCA methodologies do not hinder Patient Access and the innovation of ATMPs in Europe.

Read the press release.”

Source: CPE/LinkedIn

Alliance for Regenerative Medicine ATMPs cancer Cancer Patients Europe CPE Fondazione Telethon HTA Coordination Group JCA Joint Clinical Assessment OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Special Coverage